On January 16, an interview with Prof. Frederik De Smet was published, marking his appointment as the project coordinator of GLIOMATCH. This Horizon Europe project is sponsored by the EU, Switzerland, and the UK.

GLIOMATCH brings together 14 partners from 10 member states, all united in the mission to better understand how immunotherapy can be used to treat malignant brain tumours in both adults and children.

Stay tuned as we follow the progress of this groundbreaking project and its potential to revolutionize brain tumour treatments through advanced immunotherapy research.
Link to interview:Belg die vriend verloor aan hersenkanker leidt Europees onderzoek | De Tijd